within Pharmacolibrary.Drugs.R_RespiratorySystem.R03B_OtherDrugsForObstructiveAirwayDiseasesInhalants.R03BA04_Betamethasone;

model Betamethasone
  extends Pharmacolibrary.Drugs.ATC.R.R03BA04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R03BA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Betamethasone is a potent synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties. It is used for treating various allergic, inflammatory, and autoimmune disorders, and is also used for fetal lung maturation in preterm labor. This drug is approved and used in clinical practice, although specific administrations and indications may vary by region.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for oral administration in healthy adult population, as no direct publications for R03BA04 exist. Parameters are derived from general knowledge of betamethasone and clinical pharmacology references.</p><h4>References</h4><ol><li><p>Jobe, AH, et al., &amp; Jusko, WJ (2020). Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. <i>Clinical and translational science</i> 13(2) 391–399. DOI:<a href=&quot;https://doi.org/10.1111/cts.12724&quot;>10.1111/cts.12724</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31808984/&quot;>https://pubmed.ncbi.nlm.nih.gov/31808984</a></p></li><li><p>Schmidt, AF, et al., &amp; Kemp, MW (2019). Oral antenatal corticosteroids evaluated in fetal sheep. <i>Pediatric research</i> 86(5) 589–594. DOI:<a href=&quot;https://doi.org/10.1038/s41390-019-0519-0&quot;>10.1038/s41390-019-0519-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31365919/&quot;>https://pubmed.ncbi.nlm.nih.gov/31365919</a></p></li><li><p>Krzyzanski, W, et al., &amp; Jusko, WJ (2021). Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women. <i>Journal of pharmacokinetics and pharmacodynamics</i> 48(2) 261–272. DOI:<a href=&quot;https://doi.org/10.1007/s10928-020-09730-z&quot;>10.1007/s10928-020-09730-z</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33389521/&quot;>https://pubmed.ncbi.nlm.nih.gov/33389521</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Betamethasone;
